Patents by Inventor Paul Chen

Paul Chen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10413788
    Abstract: Embodiments of golf club heads with turbulators and methods to manufacture golf club heads with turbulators are generally described herein. In many embodiments, the turbulators are located on the crown and include a plurality of ridges disposed on the crown. Each ridge includes a base, a top surface, a ridge apex, a front surface, and a rear surface. The turbulators are positioned on the forward most portion of the crown. Other embodiments may be described and claimed.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: September 17, 2019
    Assignee: Karsten Manufacturing Corporation
    Inventors: Erik M. Henrikson, Paul D. Wood, John Hart, Marty R. Jertson, Ryan M. Stokke, Xiaojian Chen
  • Publication number: 20190280171
    Abstract: A lighting assembly is disclosed which includes a leadframe and at least one light-emitting diode (LED) element arranged on the leadframe. At least a portion of the leadframe is covered with a polyurethane coating arranged to electrically insulate the portion of the leadframe, and at least a portion of the polyurethane covered portion of the leadframe is further covered with a thermally conductive material. A method for manufacturing the lighting assembly is also disclosed.
    Type: Application
    Filed: May 16, 2017
    Publication date: September 12, 2019
    Applicant: Lumileds LLC
    Inventors: Nan CHEN, Hiu Tung CHU, Dong PAN, Paul Scott MARTIN, Tomonari ISHIKAWA
  • Publication number: 20190275008
    Abstract: Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions. Compounds of Formula (I) and Formula (II) have the following structures: (I); (II). Intermediates (V) are also claimed.
    Type: Application
    Filed: November 3, 2017
    Publication date: September 12, 2019
    Applicant: AMGEN INC.
    Inventors: Matthew BROWN, Ning CHEN, Xiaoqi CHEN, Yinhong CHEN, Alan C. CHENG, Richard V. CONNORS, Jeffrey DEIGNAN, Paul John DRANSFIELD, Xiaohui DU, Zice FU, James S. HARVEY, Julie Anne HEATH, Lars V. HEUMANN, Jonathan HOUZE, Frank KAYSER, Aarif Yusuf KHAKOO, David j. KOPECKY, Su-Jen LAI, Zhihua MA, Julio C. MEDINA, Jeffrey T. MIHALIC, Steven H. OLSON, Vatee PATTAROPONG, Gayathri SWAMINATH, Xiaodong WANG, Malgorzata WANSKA, Wen-Chen YEH
  • Publication number: 20190276345
    Abstract: The present invention relates to a process for flocculating and dewatering an aqueous mineral suspension. Said process comprises mixing a powdered poly(ethylene oxide) (co)polymer with the aqueous mineral suspension. Said method is particularly useful for the treatment of suspensions of particulate material, especially waste mineral slurries, especially for the treatment of tailings and other waste material resulting from mineral processing, in particular, the processing of oil sands tailings.
    Type: Application
    Filed: September 11, 2017
    Publication date: September 12, 2019
    Applicant: Dow Global Technologies LLC
    Inventors: Lizbeth ROSTRO, Wu CHEN, Paul A. GILLIS, Jason S. MOORE, Michael K. POINDEXTER, Harpeet SINGH
  • Publication number: 20190275355
    Abstract: This invention relates to oral care compositions comprising zingerone, bisabolol, a stannous ion source, zinc oxide, and zinc citrate, as well as to methods of using and of making these compositions.
    Type: Application
    Filed: May 29, 2019
    Publication date: September 12, 2019
    Applicant: Colgate-Palmolive Company
    Inventors: Ying YANG, Dandan CHEN, Robert D'AMBROGIO, Paul THOMSON, Harsh Mahendra TRIVEDI, Michael PRENCIPE, James MASTERS, Stanislav JARACZ
  • Publication number: 20190270813
    Abstract: The present invention is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of CD32B and one binding site specific for an epitope of CD79b (i.e., a “CD32B×CD79b bi-specific monovalent Fc diabody”). The bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to CD32B and CD79b. The invention is directed to such compositions, to pharmaceutical compositions that contain such bi-specific monovalent Fc diabodies and to methods for their use in the treatment of inflammatory diseases or conditions, and in particular, systemic lupus erythematosus (SLE) and graft vs. host disease.
    Type: Application
    Filed: May 15, 2019
    Publication date: September 5, 2019
    Applicant: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Kalpana Shah, Ezio Bonvini, Paul A. Moore, Wei Chen
  • Publication number: 20190271998
    Abstract: A power supply includes a power converter, a reference voltage generator, and a controller. During operation, the power converter produces an output voltage to power a load. The reference voltage generator (such as a voltage mode amplifier circuit) generates a floor reference voltage, a magnitude of which varies as a function of the output voltage error. The controller compares an output voltage feedback signal (derived from the output voltage) to the floor reference voltage to produce control output to control timing of activating switches in the power converter to maintain the output voltage within a desired voltage range.
    Type: Application
    Filed: March 1, 2018
    Publication date: September 5, 2019
    Inventors: Paul Sisson, Keng Chen
  • Publication number: 20190273435
    Abstract: A power supply includes a power converter, a reference voltage generator, and a controller. During operation, the power converter produces an output voltage to power a load. The reference voltage generator (such as a voltage mode amplifier circuit) generates a floor reference voltage, a magnitude of which varies as a function of the output voltage. The controller compares an output voltage feedback signal (derived from the output voltage) to the floor reference voltage to produce control output to control timing of activating switches in the power converter to maintain the output voltage within a desired voltage range.
    Type: Application
    Filed: March 1, 2018
    Publication date: September 5, 2019
    Inventors: Anthony B. Candage, Keng Chen, Paul Sisson
  • Patent number: 10404817
    Abstract: Systems, methods, and non-transitory computer readable media can obtain a first event stream including one or more events of a first type, where each event of the first type is associated with a timestamp. A second event stream including one or more events of a second type can be obtained, where each event of the second type is associated with a timestamp. The first event stream and the second event stream can be merged to generate information associated with a metric relating to a system, based on the timestamps associated with the one or more events of the first type and the timestamps associated with the one or more events of the second type.
    Type: Grant
    Filed: December 7, 2016
    Date of Patent: September 3, 2019
    Assignee: Facebook, Inc.
    Inventors: Jordan William Frank, Hongyu Liang, Itamar Rosenn, Aleksander Gorajek, Thomas M. Lento, Fanghua Li, Siyang Chen, Vishwas Badarinath Sharma, Paul Ashton Jones, Zoe Abrams Bayen
  • Patent number: 10400564
    Abstract: The present invention relates to an in situ staged steam extraction method for removing petroleum products from a heavy oil or bitumen reservoir from subterranean locations. Specifically, each injection stage comprises a different steam composition. A steam composition may consist essentially of steam or may comprise one or more enhanced oil recovery agent.
    Type: Grant
    Filed: March 18, 2015
    Date of Patent: September 3, 2019
    Assignee: Dow Global Technologies LLC
    Inventors: Harpreet Singh, Naoko Akiya, Wu Chen, Paul A. Gillis, Abu Mokhtarul Hassan, Zubin B. Kuvadia, Biplab Mukherjee, Jorge H. Pazmino, Defne Kayrak Talay
  • Publication number: 20190263319
    Abstract: A vehicle window assembly is provided herein and includes an inner layer, an outer layer, and an interlayer therebetween. A light-producing assembly is disposed in the interlayer and includes light sources disposed to emit light toward the inner layer, an optical film configured to collimate light emitted by the light sources, and a variable-transparency switchable glazing configured to vary the transmittance of the light emitted from the light sources based on user-supplied input.
    Type: Application
    Filed: February 27, 2018
    Publication date: August 29, 2019
    Inventors: Linsheng Chen, Stuart C. Salter, Steven J. Antilla, Tom Xu, Paul Kenneth Dellock
  • Patent number: 10393798
    Abstract: An electro-optical module assembly is provided that includes a flexible substrate having a first surface and a second surface opposite the first surface, wherein the flexible substrate contains an opening located therein that extends from the first surface to the second surface. An optical component is located on the second surface of the flexible substrate and is positioned to have a surface exposed by the opening. At least one electronic component is located on a first portion of the first surface of the flexible substrate, and at least one micro-energy source is located on a second portion of the first surface of the flexible substrate.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: August 27, 2019
    Assignee: International Business Machines Corporation
    Inventors: Paul S. Andry, Qianwen Chen, Bing Dang, John U. Knickerbocker, Minhua Lu, Robert J. Polastre, Bucknell C. Webb
  • Publication number: 20190255990
    Abstract: A lamp assembly is provided herein. The lamp assembly includes a panel operably coupled with one or more projectors. A light source is disposed within each of the one or more projectors. An optical member is disposed between each of the light sources and the panel. An image interference is disposed between the optical member and an exterior surface of the panel.
    Type: Application
    Filed: February 20, 2018
    Publication date: August 22, 2019
    Inventors: Stuart C. Salter, Paul Kenneth Dellock, Mehran Niksimaee, Linsheng Chen
  • Publication number: 20190248893
    Abstract: Provided herein are antibodies, or antigen-binding portions thereof, that bind to T-cell immunoglobulin and mucin-domain containing-3 (TIM3) protein. Also provided are uses of these antibodies, or antigen-binding portions thereof, in therapeutic applications, such as treatment of cancer. Further provided are cells that produce the antibodies, or antigen-binding portions thereof, polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof, and vectors comprising the polynucleotides encoding the heavy and/or light chain regions of the antibodies, or antigen-binding portions thereof.
    Type: Application
    Filed: July 13, 2017
    Publication date: August 15, 2019
    Applicant: Bristol-Myers Squibb Company
    Inventors: Xiao Min SCHEBYE, Mark J. SELBY, Michelle Minhua HAN, Christine BEE, Andy X. DENG, Anan CHUNTHARAPAI, Brigitte DEVAUX, Huiming LI, Paul O. SHEPPARD, Alan J. KORMAN, Daniel F. ARDOUREL, Ekaterina DEYANOVA, Richard Y. HUANG, Guodong CHEN, Michelle KUHNE, Hong-An TRUONG
  • Patent number: 10377125
    Abstract: A control system for a machine, operating on a worksite is associated with an implement, which perform additive construction operations in accordance with a pre-determined implement control plan. The system includes a positioning system, one or more implement control actuators, and a controller. The positioning system is configured to determine positioning signals associated with, at least, a terrain of the worksite and any worksite objects existing thereon. The controller determine an available zone, in which the machine and implement are capable of executing the additive construction operations within the available zone, based on the positioning signals and the pre-determined implement control plan, and determine an operation zone, relative to a desired additive construction site on the worksite, within the available zone, wherein parameters of the operation zone are based, at least in part, on the available zone, the machine configuration, and the pre-determined implement control plan.
    Type: Grant
    Filed: December 9, 2016
    Date of Patent: August 13, 2019
    Assignee: Caterpillar Inc.
    Inventors: Paul Friend, Qi Chen, Jean-Jacques Clar
  • Publication number: 20190235188
    Abstract: A interconnection system includes a panel side kit and a wall-mount kit coupled with each other and secured together via magnetic forces. The wall-mount kit includes a printed circuit board enclosed within a bracket and defining a center region for power transmission and a pair of side regions for high speed transmission. In the side regions, on the coupling side a plurality of wireless transmission units are located while on the back side a plurality of ROSA OE modules are provided to transfer the optical signal from optical fibers to the electronic signal for wireless transmission wherein the optical fibers are linked to a control box via a plurality of TOSA EO modules. The panel side kit includes wireless receiving units that interact with the wireless transmission units, and a plurality of connectors with the body of the display.
    Type: Application
    Filed: January 3, 2019
    Publication date: August 1, 2019
    Inventors: SHIH-WEI HSIAO, HSIU-YUAN HSU, WEI-CHIH LIN, SHUO-HSIU HSU, YEN-HSU KO, CHIH-CHUNG HSIEH, CHENG-KAI HUANG, PAUL CHEN, GENN-SHENG LEE, JIA-HAU LIU, MAO-CHUN WENG, WAYNE CHOU
  • Publication number: 20190227077
    Abstract: This disclosure relates to assays for detecting activating antibodies in a sample that are capable of antibody-dependent cell-mediated cytotoxicity. In certain embodiments, this disclosure relates to target cells comprising an antigen on the exterior of the cells and a luciferase inside the cells. In certain embodiments, the antigen is an Ebola-virus glycoprotein. In certain embodiments, this disclosure relates to detecting changes in chemiluminescence of the luciferase as an indication of activating antibodies in a sample capable of cell lysis when mixed with effector cells.
    Type: Application
    Filed: January 25, 2019
    Publication date: July 25, 2019
    Inventors: Paul Spearman, Karnail Singh, Xuemin Chen
  • Patent number: 10358490
    Abstract: The present invention relates to antagonizing the activity of IL-17A, IL-17F and IL-23 using bispecific antibodies that comprise a binding entity that is cross-reactive for IL-17A and IL-17F and a binding entity that binds IL-23p19. The present invention relates to novel bispecific antibody formats and methods of using the same.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: July 23, 2019
    Assignee: BRISTOL-MYERS SQUIBB COMPANY
    Inventors: Brenda L. Stevens, Alison Witte, Mark W. Rixon, Josephine M. Cardarelli, Thomas D. Kempe, Scott R. Presnell, Mohan Srinivasan, Susan C. Wong, Guodong Chen, Hui Wei, Stanley R. Krystek, Lumelle A. Schneeweis, Paul O. Sheppard, Indrani Chakraborty
  • Publication number: 20190218176
    Abstract: The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistance and hyperglycemia. The present invention also provides for processes of making the compounds of Formula I, including salts and co-crystals thereof and pharmaceutical compositions comprising the same.
    Type: Application
    Filed: March 25, 2019
    Publication date: July 18, 2019
    Inventors: Jorge E. GOMEZ-GALENO, Raja K. Reddy, Paul D. Van Poelje, Robert Huerta Lemus, Thanh Huu Nguyen, Matthew P. Grote, Qun Dang, Scott J. Hecker, Venkat Reddy Mali, Mingwei Chen, Zhili Sun, Serge Henri Boyer, Haiqing Li, William Craigo
  • Patent number: 10344092
    Abstract: The present invention is directed to bi-specific monovalent diabodies that comprise an immunoglobulin Fc Domain (“bi-specific monovalent Fc diabodies”) and are composed of three polypeptide chains and which possess at least one binding site specific for an epitope of CD32B and one binding site specific for an epitope of CD79b (i.e., a “CD32B×CD79b bi-specific monovalent Fc diabody”). The bi-specific monovalent Fc diabodies of the present invention are capable of simultaneous binding to CD32B and CD79b. The invention is directed to such compositions, to pharmaceutical compositions that contain such bi-specific monovalent Fc diabodies and to methods for their use in the treatment of inflammatory diseases or conditions, and in particular, systemic lupus erythematosus (SLE) and graft vs. host disease.
    Type: Grant
    Filed: August 6, 2014
    Date of Patent: July 9, 2019
    Assignee: MacroGenics, Inc.
    Inventors: Leslie S. Johnson, Ling Huang, Kalpana Shah, Ezio Bonvini, Paul A. Moore, Wei Chen